Cargando…

Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer

BACKGROUND: Prevalence of comorbidity at breast cancer diagnosis increases with age and is likely to influence the likelihood of receiving treatment according to guidelines. The aim of this study was to examine the effect of breast cancer treatment on mortality, taking age at diagnosis and comorbidi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Land, L H, Dalton, S O, Jensen, M-B, Ewertz, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504938/ https://www.ncbi.nlm.nih.gov/pubmed/23079577 http://dx.doi.org/10.1038/bjc.2012.472

Ejemplares similares

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
por: Cronin-Fenton, D P, et al.
Publicado: (2007)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study
por: Harborg, Sixten, et al.
Publicado: (2020)

'Socioeconomic position and survival after cervical cancer: influence of cancer stage, comorbidity and smoking among Danish women diagnosed between 2005 and 2010
por: Ibfelt, E H, et al.
Publicado: (2013)

Surgical treatment of early stage breast cancer in elderly: an international comparison
por: Kiderlen, M., et al.
Publicado: (2011)

Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)
por: Cold, S, et al.
Publicado: (2005)

Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer
por: Christensen, Carina Ørts, et al.
Publicado: (2016)

Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology
por: Inwald, EC, et al.
Publicado: (2017)

Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands
por: Heeg, E., et al.
Publicado: (2020)

The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999
por: Dalton, S O, et al.
Publicado: (2006)

Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
por: Arpino, Grazia, et al.
Publicado: (2015)

Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion
por: Koppelmans, Vincent, et al.
Publicado: (2020)

Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA
por: Ragusi, M. A. A., et al.
Publicado: (2022)

Long-term subjective cognitive functioning following adjuvant systemic treatment: 7–9 years follow-up of a nationwide cohort of women treated for primary breast cancer
por: Amidi, A, et al.
Publicado: (2015)

Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study
por: Ewertz, M, et al.
Publicado: (2005)

The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer
por: Terman, Elizabeth, et al.
Publicado: (2023)

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
por: Drooger, Jan C., et al.
Publicado: (2015)

Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey
por: Vandraas, K., et al.
Publicado: (2022)

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality
por: Makubate, B, et al.
Publicado: (2013)

The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors
por: de Ligt, K. M., et al.
Publicado: (2019)

Patient perspectives on window of opportunity clinical trials in early-stage breast cancer
por: Parikh, Divya A., et al.
Publicado: (2022)

The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987–2009: a registry-based cohort study
por: Grann, A F, et al.
Publicado: (2013)

Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen
por: van Nuland, M., et al.
Publicado: (2018)

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
por: Kriege, M, et al.
Publicado: (2014)

Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001–2008
por: Dalton, S O, et al.
Publicado: (2011)

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
por: Drooger, Jan C., et al.
Publicado: (2016)

Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer
por: Downing, A, et al.
Publicado: (2007)

The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients
por: Gregorowitsch, M. L., et al.
Publicado: (2019)

Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison
por: de Boer, Anna Z., et al.
Publicado: (2020)

Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
por: Park, Ko Un, et al.
Publicado: (2021)

The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands
por: Filipe, M. D., et al.
Publicado: (2021)

Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts
por: Gherghe, Ana Maria, et al.
Publicado: (2015)

The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
por: van Dooijeweert, C., et al.
Publicado: (2021)

Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish Population-based Cohort Study
por: Nørgaard, M, et al.
Publicado: (2006)

Early-stage breast cancer is not associated with the risk of marital dissolution in a large prospective study of women
por: Laitala, V S, et al.
Publicado: (2015)

21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013
por: Parsons, Benjamin M., et al.
Publicado: (2016)

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
por: Schaapveld, Michael, et al.
Publicado: (2007)

Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer
por: Fadelu, Temidayo A., et al.
Publicado: (2022)

Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark – a nationwide study
por: Frederiksen, B L, et al.
Publicado: (2012)

Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England
por: Jack, R H, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_f280huc6172tbusqbksr6juhu3